IP Library Assignment 027770/0880
Patent Assignment
Reel/Frame 027770/0880

Change of Name

Recorded: 2012-02-27 Pages: 2
Assignor
SCHWARZ PHARMA LIMITED
Executed: 2011-07-18
Assignee
UCB MANUFACTURING IRELAND LIMITED
SHANNON INDUSTRIAL ESTATE, SHANNON, CO. CLARE, IRELAND
Covered Property (1)
Method for Producing a Transdermal Therapeutic System Which Contains a D2 Agonist
Application: 10/936,620 →
Publication: US 2005/0033065
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 20, 2005
From: ADERIS PHARMACEUTICALS, INC.
To: SCHWARZ PHARMA LIMITED
Reel/Frame 016283/0716 →
Change of Name Feb 27, 2012
From: MULLER, WALTER; PECK, JAMES V.
To: LTS LOHMANN THERAPIE-SYSTEME AG; DISCOVERY THERAPEUTICS, INC.
Reel/Frame 027769/0321 →
Change of Name Feb 27, 2012
From: DISCOVERY THERAPEUTICS, INC.
To: ADERIS PHARMACEUTICALS, INC.
Reel/Frame 027770/0865 →
Corrective Assignment to Correct the Nature of Conveyance from Change of Name to Assignment Previously Recorded on Reel 027769 Frame 0321. Assignor(S) Hereby Confirms the Change of Name. Mar 1, 2012
From: MULLER, WALTER; PECK, JAMES V
To: LTS LOHMANN THERAPIE-SYSTEME AG; DISCOVERY THERAPEUTICS, INC.
Reel/Frame 027793/0328 →
Assignment of Assignor's Interest Feb 20, 2019
From: UCB MANUFACTURING IRELAND LIMITED
To: UCB BIOPHARMA SPRL
Reel/Frame 048388/0406 →